Lytic Solutions

Executive Summary

Lytic Solutions is a San Francisco-based provider of high-quality affinity reagents, molecular biology tools, and contract research and manufacturing (CRO & CMO) services, founded in 2019. The company differentiates itself through its team of PhD scientists who tackle complex projects in protein expression, assay development, and genomics, offering premium service and fast delivery. By integrating AI and machine learning into its drug delivery and reagent optimization workflows, Lytic is well-positioned to capture growing demand from biopharma and academic researchers seeking reliable, accelerate R&D timelines. As a private company, Lytic Solutions has yet to disclose funding or valuation, but its reputation for quality and speed positions it for steady organic growth. The company's focus on customer-centric solutions and its ability to handle challenging projects should drive recurring revenue and expand its client base. With the broader trend toward outsourcing non-core R&D activities, Lytic is poised to benefit as biotech and pharma companies seek agile partners. Key pathways include scaling its reagent catalog, expanding CMO capacity, and leveraging AI for predictive protein engineering. The company's modest profile suggests room for rapid upside if it secures strategic partnerships or develops a proprietary platform.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-powered reagent design platform60% success
• Q4 2026Strategic partnership with a mid-tier biopharma for CRO services50% success
• H1 2027Expansion of CMO capacity for GMP-grade reagents40% success